GAUSS-3: Statin intolerance a real problem and PCSK9 inhibition with evolocumab effective - PACE-CME

GAUSS Statin intolerance a real problem and PCSK inhibition with evolocumab effective

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

MinuteCE®
Clinical scenarios addressing residual risk in ASCVD: Understanding the role of triglycerides and EPA
0.50 credits 3 episodes
- Prof. Alberto Zambon MD, PhD, FAHA
- Prof. Kausik Ray, MBChB, MD, MPhil
- Azfar Zaman, MD
0.50 credits 3 episodes
MinuteCE®
Innovating the clinical management of LDL-c: Exploring CETP as therapeutic target
0.50 credits 3 episodes
- John Kastelein, MD, PhD
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
- Erin D. Michos, MD, MHS, FACC, FAHA, FASE
0.50 credits 3 episodes
The current state of secondary prevention in high-risk patients
The current state of secondary prevention in high-risk patients
Hyperlipidemia
The current state of secondary prevention in high-risk patients
- Prof. Thomas Lüscher, MD
Integrating EPA in CV risk reduction strategies: Practical experience and guidance
Integrating EPA in CV risk reduction strategies: Practical experience and guidance
MinuteCE®
Integrating EPA in CV risk reduction strategies: Practical experience and guidance
0.50 program credits
- Azfar Zaman, MD
0.50 program credits